Theraclion S.A. (TCLIF)
Theraclion S.A. operates in the Medical - Devices industry of the Healthcare sector, headquartered in Malakoff, IF, FR. The stock last traded at $0.53, up 0.00% on the session, giving a market capitalisation of $38.9M. On trailing twelve-month figures it carries a trailing P/E of -5.70, a net margin of -479.8%. Its beta of 0.39 implies it has historically moved less than the broad market.
Theraclion SA specializes in developing advanced echotherapy devices that harness high-intensity focused ultrasound technology. Its product portfolio includes SONOVEIN, a robotic, non-surgical echotherapy system specifically designed for treating varicose veins. Another key offering is ECHOPULSE, also a robotic and non-invasive echotherapy solution, utilized for addressing thyroid nodules and breast fibroadenomas. The company further provides EPack, a disposable accessory that attaches to the treatment device to ensure patient skin protection and improve imaging precision. Founded in 2004, Theraclion SA is headquartered in Malakoff, France.
Theraclion S.A. is most often compared with the following Healthcare names: